vs
EZCORP INC(EZPW)与Royalty Pharma plc(RPRX)财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是EZCORP INC的1.6倍($622.0M vs $382.0M),Royalty Pharma plc净利率更高(34.4% vs 11.6%,领先22.8%),EZCORP INC同比增速更快(19.3% vs 4.8%),过去两年EZCORP INC的营收复合增速更高(15.6% vs 4.6%)
EZCORP是总部位于美国得克萨斯州奥斯汀的典当行运营商,业务覆盖美国及拉丁美洲地区,是美国第二大典当行运营商,仅次于Cash America International,目前在纳斯达克挂牌上市。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业,专注于研发可调节转化生长因子β(TGF-β)超家族蛋白的药物,该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
EZPW vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.6倍
$382.0M
营收增速更快
EZPW
高出14.5%
4.8%
净利率更高
RPRX
高出22.8%
11.6%
两年增速更快
EZPW
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $382.0M | $622.0M |
| 净利润 | $44.3M | $214.2M |
| 毛利率 | 58.4% | — |
| 营业利润率 | 15.9% | 62.4% |
| 净利率 | 11.6% | 34.4% |
| 营收同比 | 19.3% | 4.8% |
| 净利润同比 | 42.8% | 2.9% |
| 每股收益(稀释后) | $0.55 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
EZPW
RPRX
| Q4 25 | $382.0M | $622.0M | ||
| Q3 25 | $336.8M | $609.3M | ||
| Q2 25 | $311.0M | $578.7M | ||
| Q1 25 | $306.3M | $568.2M | ||
| Q4 24 | $320.2M | $593.6M | ||
| Q3 24 | $294.6M | $564.7M | ||
| Q2 24 | $281.4M | $537.3M | ||
| Q1 24 | $285.6M | $568.0M |
净利润
EZPW
RPRX
| Q4 25 | $44.3M | $214.2M | ||
| Q3 25 | $26.7M | $288.2M | ||
| Q2 25 | $26.5M | $30.2M | ||
| Q1 25 | $25.4M | $238.3M | ||
| Q4 24 | $31.0M | $208.2M | ||
| Q3 24 | $15.2M | $544.0M | ||
| Q2 24 | $17.9M | $102.0M | ||
| Q1 24 | $21.5M | $4.8M |
毛利率
EZPW
RPRX
| Q4 25 | 58.4% | — | ||
| Q3 25 | 59.0% | — | ||
| Q2 25 | 59.1% | — | ||
| Q1 25 | 58.3% | — | ||
| Q4 24 | 57.9% | — | ||
| Q3 24 | 59.5% | — | ||
| Q2 24 | 59.2% | — | ||
| Q1 24 | 58.7% | — |
营业利润率
EZPW
RPRX
| Q4 25 | 15.9% | 62.4% | ||
| Q3 25 | 11.0% | 70.1% | ||
| Q2 25 | 11.6% | 36.3% | ||
| Q1 25 | 11.2% | 94.0% | ||
| Q4 24 | 13.1% | 60.9% | ||
| Q3 24 | 8.8% | — | ||
| Q2 24 | 7.9% | 50.2% | ||
| Q1 24 | 9.6% | -13.0% |
净利率
EZPW
RPRX
| Q4 25 | 11.6% | 34.4% | ||
| Q3 25 | 7.9% | 47.3% | ||
| Q2 25 | 8.5% | 5.2% | ||
| Q1 25 | 8.3% | 41.9% | ||
| Q4 24 | 9.7% | 35.1% | ||
| Q3 24 | 5.2% | 96.3% | ||
| Q2 24 | 6.4% | 19.0% | ||
| Q1 24 | 7.5% | 0.8% |
每股收益(稀释后)
EZPW
RPRX
| Q4 25 | $0.55 | $0.49 | ||
| Q3 25 | $0.35 | $0.67 | ||
| Q2 25 | $0.34 | $0.07 | ||
| Q1 25 | $0.33 | $0.55 | ||
| Q4 24 | $0.40 | $0.46 | ||
| Q3 24 | $0.20 | $1.21 | ||
| Q2 24 | $0.25 | $0.23 | ||
| Q1 24 | $0.29 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $465.9M | $618.7M |
| 总债务越低越好 | $518.6M | $9.0B |
| 股东权益账面价值 | $1.1B | $9.7B |
| 总资产 | $2.0B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.48× | 0.92× |
8季度趋势,按日历期对齐
现金及短期投资
EZPW
RPRX
| Q4 25 | $465.9M | $618.7M | ||
| Q3 25 | $469.5M | $938.9M | ||
| Q2 25 | $472.1M | $631.9M | ||
| Q1 25 | $505.2M | $1.1B | ||
| Q4 24 | $174.5M | $929.0M | ||
| Q3 24 | $170.5M | $950.1M | ||
| Q2 24 | $218.0M | $1.8B | ||
| Q1 24 | $229.1M | $843.0M |
总债务
EZPW
RPRX
| Q4 25 | $518.6M | $9.0B | ||
| Q3 25 | $518.1M | $8.9B | ||
| Q2 25 | $517.6M | $8.0B | ||
| Q1 25 | $620.5M | $7.6B | ||
| Q4 24 | $327.7M | $7.6B | ||
| Q3 24 | $327.3M | $7.6B | ||
| Q2 24 | $361.3M | $7.6B | ||
| Q1 24 | $360.9M | $6.1B |
股东权益
EZPW
RPRX
| Q4 25 | $1.1B | $9.7B | ||
| Q3 25 | $1.0B | $9.6B | ||
| Q2 25 | $990.1M | $9.5B | ||
| Q1 25 | $851.6M | $9.8B | ||
| Q4 24 | $823.9M | $10.3B | ||
| Q3 24 | $804.6M | $10.3B | ||
| Q2 24 | $801.5M | $9.8B | ||
| Q1 24 | $800.4M | $9.9B |
总资产
EZPW
RPRX
| Q4 25 | $2.0B | $19.6B | ||
| Q3 25 | $2.0B | $19.3B | ||
| Q2 25 | $1.9B | $18.3B | ||
| Q1 25 | $1.8B | $17.6B | ||
| Q4 24 | $1.5B | $18.2B | ||
| Q3 24 | $1.5B | $18.0B | ||
| Q2 24 | $1.5B | $17.7B | ||
| Q1 24 | $1.5B | $16.1B |
负债/权益比
EZPW
RPRX
| Q4 25 | 0.48× | 0.92× | ||
| Q3 25 | 0.51× | 0.93× | ||
| Q2 25 | 0.52× | 0.84× | ||
| Q1 25 | 0.73× | 0.78× | ||
| Q4 24 | 0.40× | 0.74× | ||
| Q3 24 | 0.41× | 0.74× | ||
| Q2 24 | 0.45× | 0.78× | ||
| Q1 24 | 0.45× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $39.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $31.7M | — |
| 自由现金流率自由现金流/营收 | 8.3% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | 0.88× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $121.7M | — |
8季度趋势,按日历期对齐
经营现金流
EZPW
RPRX
| Q4 25 | $39.1M | $827.1M | ||
| Q3 25 | $51.3M | $702.6M | ||
| Q2 25 | $34.8M | $364.0M | ||
| Q1 25 | $36.9M | $596.1M | ||
| Q4 24 | $26.0M | $742.5M | ||
| Q3 24 | $43.3M | $703.6M | ||
| Q2 24 | $33.7M | $658.2M | ||
| Q1 24 | $15.1M | $664.6M |
自由现金流
EZPW
RPRX
| Q4 25 | $31.7M | — | ||
| Q3 25 | $35.7M | — | ||
| Q2 25 | $25.7M | — | ||
| Q1 25 | $28.6M | — | ||
| Q4 24 | $20.4M | — | ||
| Q3 24 | $24.4M | — | ||
| Q2 24 | $30.5M | — | ||
| Q1 24 | $8.6M | — |
自由现金流率
EZPW
RPRX
| Q4 25 | 8.3% | — | ||
| Q3 25 | 10.6% | — | ||
| Q2 25 | 8.3% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 6.4% | — | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | 10.8% | — | ||
| Q1 24 | 3.0% | — |
资本支出强度
EZPW
RPRX
| Q4 25 | 2.0% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 6.4% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 2.3% | — |
现金转化率
EZPW
RPRX
| Q4 25 | 0.88× | 3.86× | ||
| Q3 25 | 1.92× | 2.44× | ||
| Q2 25 | 1.31× | 12.06× | ||
| Q1 25 | 1.45× | 2.50× | ||
| Q4 24 | 0.84× | 3.57× | ||
| Q3 24 | 2.85× | 1.29× | ||
| Q2 24 | 1.88× | 6.45× | ||
| Q1 24 | 0.70× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EZPW
| Merchandise | $210.1M | 55% |
| Pawn Service | $131.9M | 35% |
| Jewelry Scrap | $39.9M | 10% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |